Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pelletier

Showing results (311-320 of 314) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 314 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 12, 2021
Randomized prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic testDeanna G Brockman, Christina A Austin-Tse, Renée C Pelletier, et al.
The Journal of Investigative Dermatology|March 30, 2023
A Spontaneous Melanoma Mouse Model Applicable for a Longitudinal Chemotherapy and Immunotherapy StudyKevinn Eddy, Kajal Gupta, Jeffrey C Pelletier, et al.
Journal of Medicinal Chemistry|March 11, 2009
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R)Jeffrey C Pelletier, Murty V Chengalvala, Joshua E Cottom, et al.
Journal of Medicinal Chemistry|October 28, 2009
(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rateJeffrey C Pelletier, Joseph T Lundquist, Adam M Gilbert, et al.
Pageof 32

Showing results (311-320 of 314) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 314 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 12, 2021
Randomized prospective evaluation of genome sequencing versus standard-of-care as a first molecular diagnostic testDeanna G Brockman, Christina A Austin-Tse, Renée C Pelletier, et al.
The Journal of Investigative Dermatology|March 30, 2023
A Spontaneous Melanoma Mouse Model Applicable for a Longitudinal Chemotherapy and Immunotherapy StudyKevinn Eddy, Kajal Gupta, Jeffrey C Pelletier, et al.
Journal of Medicinal Chemistry|March 11, 2009
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R)Jeffrey C Pelletier, Murty V Chengalvala, Joshua E Cottom, et al.
Journal of Medicinal Chemistry|October 28, 2009
(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rateJeffrey C Pelletier, Joseph T Lundquist, Adam M Gilbert, et al.
Pageof 32